A randomised comparison of two different methods of intrabronchial lignocaine delivery during flexible bronchoscopy

A randomised, controlled, open label, prospective, single centre study to investigate the use of the ENK device when compared to the standard syringe administration of 2% lignocaine solution when performing diagnostic flexible bronchoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN77331907

Enrollment

100

Registered

2010-03-16

Start date

2004-05-05

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Local anaesthetic delivery in bronchoscopy Surgery Anaesthesia

Interventions

Administration of local anaesthetic via either the standard "spray as you go" technique or nebulised through the bronchoscope via the ENK device (which has been used to assist in awake intubations pre

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All adult patients (either sex) attending Royal Preston Hospital for diagnostic flexible bronchoscopy

Exclusion criteria

Exclusion criteria: Patients undergoing interventional procedures (e.g. tracheobronchial stenting, transbronchial biopsy or intrluminal palliative therapies)

Design outcomes

Primary

Measure	Time frame
Visual analoque scale assessments by doctor, nurse and patient regarding ease of procedure, extent of coughing and patient tolerance. Doctor and nurse questionnaires completed immediately following the procedure. Patient questionnaires completed more than 24 hours later (to ensure there is no lasting effect of any sedative medication used).	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026